NanoViricides Inc. (NNVC) is a publicly traded Healthcare sector company. As of July 6, 2026, NNVC trades at $1.46 with a market cap of $30.57M and a P/E ratio of -2.11. NNVC moved +7.14% today. Year to date, NNVC is +20.91%; over the trailing twelve months it is -4.32%. Its 52-week range spans $0.85 to $2.23. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces NNVC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for NNVC, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.46 |
| Market Cap | $30.57M |
| P/E Ratio | -2.11 |
| EPS | $-0.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.23 |
| 52-Week Low | $0.85 |
| Volume | 239.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-9.47M |
| Gross Margin | 0.00% |
1 analysts cover NNVC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.